Primary care management of chronic insomnia: a qualitative analysis of the attitudes and experiences of Australian general practitioners.
Australia
Family practice
General practice
General practitioners
Insomnia
Primary care
Qualitative research
Sleep
Journal
BMC family practice
ISSN: 1471-2296
Titre abrégé: BMC Fam Pract
Pays: England
ID NLM: 100967792
Informations de publication
Date de publication:
22 07 2021
22 07 2021
Historique:
received:
02
12
2020
accepted:
20
04
2021
entrez:
23
7
2021
pubmed:
24
7
2021
medline:
25
9
2021
Statut:
epublish
Résumé
Chronic insomnia is a highly prevalent disorder, with ten to thirty percent of Australian adults reporting chronic difficulties falling asleep and/or staying asleep such that it causes significant daytime impairment. Current Australian general practice guidelines recommend cognitive behavioural therapy for insomnia (CBTi) as first line treatment for insomnia, however research suggests that most general practice consultations for insomnia result in a prescription for hypnotic or sedative medicines. Although the first point of contact for patients experiencing symptoms of insomnia is often general practice, little is known about the current role, experiences and capacity of Australian general practitioners to manage insomnia. This study aimed to address that gap by exploring the attitudes and opinions of general practitioners regarding insomnia management, to inform the development and implementation of new models of best practice insomnia care within general practice. A descriptive, pragmatic qualitative study. Purposive sampling was used to recruit practising Australian general practitioners, varying in age, years of experience and geographic location. Semi-structured interviews were conducted, and data analysed using thematic analysis. RESULTS: Twenty-eight general practitioners participated in the study. Three major themes were identified: 1) Responsibility for insomnia care; 2) Complexities in managing insomnia; and 3) Navigating treatment pathways. Whilst general practitioners readily accepted responsibility for the management of insomnia, provision of care was often demanding and difficult within the funding and time constraints of general practice. Patients presenting with comorbid mental health conditions and insomnia, and decision-making regarding long-term use of benzodiazepines presented challenges for general practitioners. Whilst general practitioners confidently provided sleep hygiene education to patients, their knowledge and experience of CBTi, and access and understanding of specialised referral pathways for insomnia was limited. CONCLUSIONS: General practitioners report that whilst assessing and managing insomnia can be demanding, it is an integral part of general practice. Insomnia presents complexities for general practitioners. Greater clarity about funding options, targeted education about effective insomnia treatments, and referral pathways to specialist services, such as benzodiazepine withdrawal support and psychologists, would benefit insomnia management within general practice.
Sections du résumé
BACKGROUND
Chronic insomnia is a highly prevalent disorder, with ten to thirty percent of Australian adults reporting chronic difficulties falling asleep and/or staying asleep such that it causes significant daytime impairment. Current Australian general practice guidelines recommend cognitive behavioural therapy for insomnia (CBTi) as first line treatment for insomnia, however research suggests that most general practice consultations for insomnia result in a prescription for hypnotic or sedative medicines. Although the first point of contact for patients experiencing symptoms of insomnia is often general practice, little is known about the current role, experiences and capacity of Australian general practitioners to manage insomnia. This study aimed to address that gap by exploring the attitudes and opinions of general practitioners regarding insomnia management, to inform the development and implementation of new models of best practice insomnia care within general practice.
METHODS
A descriptive, pragmatic qualitative study. Purposive sampling was used to recruit practising Australian general practitioners, varying in age, years of experience and geographic location. Semi-structured interviews were conducted, and data analysed using thematic analysis. RESULTS: Twenty-eight general practitioners participated in the study. Three major themes were identified: 1) Responsibility for insomnia care; 2) Complexities in managing insomnia; and 3) Navigating treatment pathways. Whilst general practitioners readily accepted responsibility for the management of insomnia, provision of care was often demanding and difficult within the funding and time constraints of general practice. Patients presenting with comorbid mental health conditions and insomnia, and decision-making regarding long-term use of benzodiazepines presented challenges for general practitioners. Whilst general practitioners confidently provided sleep hygiene education to patients, their knowledge and experience of CBTi, and access and understanding of specialised referral pathways for insomnia was limited. CONCLUSIONS: General practitioners report that whilst assessing and managing insomnia can be demanding, it is an integral part of general practice. Insomnia presents complexities for general practitioners. Greater clarity about funding options, targeted education about effective insomnia treatments, and referral pathways to specialist services, such as benzodiazepine withdrawal support and psychologists, would benefit insomnia management within general practice.
Identifiants
pubmed: 34294049
doi: 10.1186/s12875-021-01510-z
pii: 10.1186/s12875-021-01510-z
pmc: PMC8299615
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
158Informations de copyright
© 2021. The Author(s).
Références
Aust J Prim Health. 2014;20(1):103-12
pubmed: 24200195
Health Expect. 2015 Oct;18(5):1371-83
pubmed: 23952603
Sleep. 2009 Dec;32(12):1549-58
pubmed: 20041590
Behav Sleep Med. 2010;8(3):123-40
pubmed: 20582756
BMJ. 2005 Nov 19;331(7526):1169
pubmed: 16284208
Behav Sleep Med. 2012 Oct;10(4):266-79
pubmed: 22946736
JMIR Mhealth Uhealth. 2020 Jun 1;8(6):e16497
pubmed: 32478660
Qual Health Res. 2001 Jul;11(4):522-37
pubmed: 11521609
Sleep Med. 2017 Aug;36 Suppl 1:S43-S47
pubmed: 28648226
J Sleep Res. 2021 Feb;30(1):e13169
pubmed: 32951295
J Clin Sleep Med. 2017 Aug 15;13(8):991-999
pubmed: 28728623
Sleep Med. 2009 Apr;10(4):427-38
pubmed: 18753000
Behav Sleep Med. 2019 Jan-Feb;17(1):19-30
pubmed: 28098492
Int Rev Psychiatry. 2014 Apr;26(2):155-76
pubmed: 24892892
J Am Geriatr Soc. 2012 Oct;60(10):1803-10
pubmed: 23035962
JAMA. 2009 May 20;301(19):2005-15
pubmed: 19454639
J Sleep Res. 2016 Feb;25(1):104-15
pubmed: 26306418
Aust J Gen Pract. 2021 May;50(5):287-293
pubmed: 33928277
Br J Gen Pract. 2014 Feb;64(619):e112-9
pubmed: 24567616
J Psychopharmacol. 2019 Aug;33(8):923-947
pubmed: 31271339
Fam Pract. 2018 Jul 23;35(4):365-375
pubmed: 29194467
BMC Fam Pract. 2013 Dec 13;14:191
pubmed: 24330388
Ann Intern Med. 2016 Jul 19;165(2):125-33
pubmed: 27136449
Implement Sci Commun. 2020 Nov 30;1(1):107
pubmed: 33292865
J Clin Sleep Med. 2017 Jun 15;13(6):785-790
pubmed: 28454597
J Clin Sleep Med. 2008 Oct 15;4(5):487-504
pubmed: 18853708
Curr Psychiatry Rep. 2013 Dec;15(12):418
pubmed: 24189774
Lancet. 2012 Mar 24;379(9821):1129-41
pubmed: 22265700
Contemp Nurse. 2005 Jul-Aug;19(1-2):75-87
pubmed: 16167437
NIH Consens State Sci Statements. 2005 Jun 13-15;22(2):1-30
pubmed: 17308547
Implement Sci. 2016 Mar 22;11:40
pubmed: 27001107
Qual Quant. 2018;52(4):1893-1907
pubmed: 29937585
Sleep Med Rev. 2021 Apr;56:101404
pubmed: 33370637